ArticleClinical drug investigation2016

Cost-Effectiveness of Dapagliflozin as Add-On to Metformin for the Treatment of Type 2 Diabetes Mellitus in Greece.

Charalampos Tzanetakos et al.PubMed ↗Publisher ↗

No numbers read from the abstract.